Eight of 10 hospitalized COVID-19 patients developed neurologic complications and were six times more likely than their peers to die, according to early results from a global study published yesterday in JAMA Network Open.Many of the conditions were mild to moderate, but half of the patients had altered brain function or structure, and almost one in five were in a coma.Led by University of Pittsburgh researchers for the Global Consortium Study of Neurologic Dysfunction in COVID-19, the study involved 3,744 hospitalized adult COVID-19 patients at 28 centers in 13 countries from March to October 2020.Half have acute encephalopathyAmong the patients, 82% reported neurologic symptoms, with 37% having headaches and 26% saying they lost their